← SynDRA
GW-3965
SynDRA canonical compound SYN0059286 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | NR1H2 |
| Mechanism of action | ABC transporter expression enhancer |
All known targets
Mechanisms of action (all sources)
- LXR agonist
- ABC transporter expression enhancer
- NR1H3 AGONIST
- NR1H2 AGONIST
- NR1H2 INHIBITOR
- NR1H3 INHIBITOR
Cross-references
Synonyms
- GW 3965 (HYDROCHLORIDE)
- GW3965
- GW 3965
- UNII-6JI5YOG7RC
- 6JI5YOG7RC
- CHEMBL59030
- CHEBI:79995
- (3-{3-[[2-CHLORO-3-(TRIFLUOROMETHYL)BENZYL](2,2-DIPHENYLETHYL)AMINO]PROPOXY}PHENYL)ACETIC ACID
- 2-[3-[3-[[2-chloro-3-(trifluoromethyl)phenyl]methyl-[2,2-di(phenyl)ethyl]amino]propoxy]phenyl]acetic acid
- [3-(3-{[2-Chloro-3-(Trifluoromethyl)benzyl](2,2-Diphenylethyl)amino}propoxy)phenyl]acetic Acid
- GW 3965A
- 3-(3-[[2-chloro-3-(trifluoromethyl)benzyl)(2,2-diphenylethyl)-amino]-propoxy}-phenyl acetic acid
- RefChem:783285
- GSK-3965
- C473027
- C33H31CLF3NO3
- GTPL2754
- orb1686932
- SCHEMBL2110041
- SCHEMBL29359875
- SCHEMBL29383609
- BDBM19992
- NAXSRXHZFIBFMI-UHFFFAOYSA-M
- GLXC-04615
- HMS3742A15
- EX-A8133
- T6310L
- AKOS015856148
- CS-0842
- SB19594
- NCGC00161825-01
- NCGC00161825-02
- NCGC00161825-10
- HY-10627
- NS00069683
- G62250
- SR-03000001343
- SR-03000001343-1
- BRD-K33818169-003-01-2
Look up GW-3965 in the interactive SynDRA portal →